The influence of D-penicillamine therapy on numbers of circulating immunoglobulin secreting cells in rheumatoid arthritis.
Higher numbers of plaque forming (immunoglobulin secreting) cells have been reported among peripheral blood mononuclear cells from patients with active rheumatoid arthritis than from patients with spontaneously inactive disease. Patients treated with D-penicillamine who showed a good clinical response were found to have lower numbers of circulating plaque forming cells than were detected in the active rheumatoid group. Similar numbers of plaque forming cells were detected in patients who showed a poor clinical response to D-penicillamine as in the active rheumatoid group (untreated with 'second line' drugs). Active rheumatoid arthritis is associated with increased numbers of plaque forming cells in the peripheral blood, changes in the numbers of these cells providing an index of disease activity.
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D006462:Hemolytic Plaque Technique; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis*; D007962:Leukocytes / Q000276:immunology; D010396:Penicillamine / Q000627:therapeutic use*
D007136:Immunoglobulins; D010396:Penicillamine